BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35245698)

  • 1. The potential of prostate gland radiomic features in identifying the Gleason score.
    Gong L; Xu M; Fang M; He B; Li H; Fang X; Dong D; Tian J
    Comput Biol Med; 2022 May; 144():105318. PubMed ID: 35245698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive Prediction of High-Grade Prostate Cancer via Biparametric MRI Radiomics.
    Gong L; Xu M; Fang M; Zou J; Yang S; Yu X; Xu D; Zhou L; Li H; He B; Wang Y; Fang X; Dong D; Tian J
    J Magn Reson Imaging; 2020 Oct; 52(4):1102-1109. PubMed ID: 32212356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics Models Based on Apparent Diffusion Coefficient Maps for the Prediction of High-Grade Prostate Cancer at Radical Prostatectomy: Comparison With Preoperative Biopsy.
    Han C; Ma S; Liu X; Liu Y; Li C; Zhang Y; Zhang X; Wang X
    J Magn Reson Imaging; 2021 Dec; 54(6):1892-1901. PubMed ID: 33682286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
    Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
    Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218).
    Gugliandolo SG; Pepa M; Isaksson LJ; Marvaso G; Raimondi S; Botta F; Gandini S; Ciardo D; Volpe S; Riva G; Rojas DP; Zerini D; Pricolo P; Alessi S; Petralia G; Summers PE; Mistretta FA; Luzzago S; Cattani F; De Cobelli O; Cassano E; Cremonesi M; Bellomi M; Orecchia R; Jereczek-Fossa BA
    Eur Radiol; 2021 Feb; 31(2):716-728. PubMed ID: 32852590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Gleason score in prostate cancer patients based on radiomic features of transrectal ultrasound images.
    Cheng T; Li H
    Br J Radiol; 2024 Feb; 97(1154):415-421. PubMed ID: 38308030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings.
    Penzias G; Singanamalli A; Elliott R; Gollamudi J; Shih N; Feldman M; Stricker PD; Delprado W; Tiwari S; Böhm M; Haynes AM; Ponsky L; Fu P; Tiwari P; Viswanath S; Madabhushi A
    PLoS One; 2018; 13(8):e0200730. PubMed ID: 30169514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy.
    Zhang GM; Han YQ; Wei JW; Qi YF; Gu DS; Lei J; Yan WG; Xiao Y; Xue HD; Feng F; Sun H; Jin ZY; Tian J
    J Magn Reson Imaging; 2020 Oct; 52(4):1239-1248. PubMed ID: 32181985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically significant prostate cancer detection on MRI: A radiomic shape features study.
    Cuocolo R; Stanzione A; Ponsiglione A; Romeo V; Verde F; Creta M; La Rocca R; Longo N; Pace L; Imbriaco M
    Eur J Radiol; 2019 Jul; 116():144-149. PubMed ID: 31153556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features.
    Bernatz S; Ackermann J; Mandel P; Kaltenbach B; Zhdanovich Y; Harter PN; Döring C; Hammerstingl R; Bodelle B; Smith K; Bucher A; Albrecht M; Rosbach N; Basten L; Yel I; Wenzel M; Bankov K; Koch I; Chun FK; Köllermann J; Wild PJ; Vogl TJ
    Eur Radiol; 2020 Dec; 30(12):6757-6769. PubMed ID: 32676784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
    Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
    J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness.
    Hectors SJ; Cherny M; Yadav KK; Beksaç AT; Thulasidass H; Lewis S; Davicioni E; Wang P; Tewari AK; Taouli B
    J Urol; 2019 Sep; 202(3):498-505. PubMed ID: 30958743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-based texture analysis of the primary tumor for pre-treatment prediction of bone metastases in prostate cancer.
    Wang Y; Yu B; Zhong F; Guo Q; Li K; Hou Y; Lin N
    Magn Reson Imaging; 2019 Jul; 60():76-84. PubMed ID: 30917943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of texture analysis based on T2-weighted magnetic resonance images in discriminating Gleason scores of prostate cancer.
    Pan R; Yang X; Shu Z; Gu Y; Weng L; Jia Y; Feng J
    J Xray Sci Technol; 2020; 28(6):1207-1218. PubMed ID: 32925162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Magnetic Resonance Imaging Radiomic Features in Response to Androgen Deprivation Therapy in Patients with Intermediate- and High-risk Prostate Cancer.
    Tharmalingam H; Tsang YM; Alonzi R; Beasley W; Taylor NJ; McWilliam A; Padhani A; Choudhury A; Hoskin PJ
    Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):e246-e253. PubMed ID: 35033410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature.
    Zhang L; Zhe X; Tang M; Zhang J; Ren J; Zhang X; Li L
    Contrast Media Mol Imaging; 2021; 2021():7830909. PubMed ID: 35024015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeatability of radiomics and machine learning for DWI: Short-term repeatability study of 112 patients with prostate cancer.
    Merisaari H; Taimen P; Shiradkar R; Ettala O; Pesola M; Saunavaara J; Boström PJ; Madabhushi A; Aronen HJ; Jambor I
    Magn Reson Med; 2020 Jun; 83(6):2293-2309. PubMed ID: 31703155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A deep learning masked segmentation alternative to manual segmentation in biparametric MRI prostate cancer radiomics.
    Bleker J; Kwee TC; Rouw D; Roest C; Borstlap J; de Jong IJ; Dierckx RAJO; Huisman H; Yakar D
    Eur Radiol; 2022 Sep; 32(9):6526-6535. PubMed ID: 35420303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study.
    Hu L; Zhou DW; Fu CX; Benkert T; Jiang CY; Li RT; Wei LM; Zhao JG
    Eur Radiol; 2021 Mar; 31(3):1760-1769. PubMed ID: 32935192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.